Sweden· SE-19990226000039
CellCept 1 g/5 ml Pulver till oral suspension
A medicinal product containing mycophenolate mofetil, registered in Sweden by Roche Registration GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Mycophenolate Mofetil
- Manufacturer
- Roche Registration GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19990226000039
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mycophenolate mofetil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCellCeptGenentech, Inc.
- FinlandCellceptAbacus Medicine A/S
- BelgiumCellcept 1 g/5 mlRoche Registration
- IrelandCellCept 1 g/5 ml Powder for oral suspensionRoche Registration GmbH
- NorwayCellCeptRoche Registration GmbH
- FranceCELLCEPT 1 g/5 mL, poudre pour suspension buvableROCHE REGISTRATION (ALLEMAGNE)
- CzechiaCELLCEPTRoche Registration GmbH, Grenzach-Wyhlen
- United KingdomArzip 250mg capsulesZentiva Pharma UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mowel, Mycophenolat Mofetil Sandoz
- Belgium · Mycophenolat Mofetil Sandoz
- Bulgaria · Микофенолат Мофетил Акорд
- Czechia · Mycophenolat Mofetil Sandoz
- Germany · Mowel, Mycophenolat 1 A Pharma
- Denmark · Mycophenolate Mofetil Hexal, Mycophenolatmofetil Accord
- Estonia · Mycophenolate Mofetil Accord
- Spain · Micofenolato De Mofetilo Accord, Micofenolato De Mofetilo Aristo
- Finland · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- France · Mycophenolate Mofetil Arrow, Mycophenolate Mofetil Biogaran
- United Kingdom (Northern Ireland) · Mycophenolate Hexal, Mycophenolate Mofetil
- Croatia · Mofetilmikofenolat Tillomed, Trixin
- Ireland · Mycolat, Mycophenolate Mofetil Accord
- Iceland · Cellcept, Myclausen
- Italy · Micofenolato Mofetile Accord, Micofenolato Mofetile Ahcl
- Liechtenstein · Cellcept, Myclausen
- Lithuania · Mycophenolate Mofetil Accord
- Latvia · Mycophenolate Mofetil Accord
- Malta · Mycophenolate Mofetil Ascend
- Netherlands · Mycofenolaat Mofetil Accord, Mycofenolaat Mofetil Sandoz
- Norway · Cellcept, Myclausen
- Poland · Mycofit, Mycophenolate Mofetil Sandoz
- Portugal · Micofenolato De Mofetil Accord, Micofenolato De Mofetil Aristo
- Romania · Micofenolat Mofetil Sandoz
- Slovakia · Mykofenolát Mofetil Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/074aa38f-1bb5-42c6-8255-7ef1b8d20b40 GET /v1/drugs/074aa38f-1bb5-42c6-8255-7ef1b8d20b40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "19990226000039",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19990226000039",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/cellcept-epar-product-information_sv.pdf"
}See everything about mycophenolate mofetil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.